GUARDANT HEALTH INC (GH) Stock Price, Quote, News and Overview
NASDAQ:GH - Nasdaq - US40131M1099 - Common Stock - Currency: USD
GH Quote, Performance and Key Statistics
GUARDANT HEALTH INC
NASDAQ:GH (2/5/2025, 8:02:38 PM)
After market: 47.595 0 (0%)47.595
+0.42 (+0.9%)
The current stock price of GH is 47.595 USD. In the past month the price increased by 32.65%. In the past year, price increased by 110.5%.
GH Latest News, Press Releases and Analysis
Guardant Health to Report Fourth Quarter and Full Year 2024 Financial Results on February 20, 2025
Guardant Health’s Shield Test Selected by Abu Dhabi Department of Health for Blood-Based Colorectal Cancer Screening Program
Okla And Rigetti Computing Are Among Top 8 Mid Cap Gainers Last Week (Jan 20-Jan 24): Are The Others In Your Portfolio?
Top performers in last week's mid-cap stocks: Oklo Inc., Tempus AI, Himax Tech, Super Group, NuScale Power, WNS Holdings, Guardant Health, Rigetti Computing.
Oncology's Best Minds Set to Meet at Upcoming 2025 ASCO Gastrointestinal Cancers Symposium
/PRNewswire/ -- USA News Group News Commentary – Big developments are expected this week at the 2025 ASCO Gastrointestinal Cancers Symposium, running January...
Guardant Health Gains Medicare Coverage For Colorectal Cancer Monitoring Test
Guardant Reveal test receives expanded Medicare coverage for colorectal cancer recurrence monitoring, enhancing revenue potential and clinical adoption.
GH Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| CI | THE CIGNA GROUP | 10.73 | 81.58B | ||
| CVS | CVS HEALTH CORP | 8.77 | 70.08B | ||
| LH | LABCORP HOLDINGS INC | 17.34 | 20.91B | ||
| DGX | QUEST DIAGNOSTICS INC | 18.28 | 18.40B | ||
| DVA | DAVITA INC | 19.92 | 14.50B | ||
| BTSGU | BRIGHTSPRING HEALTH SERV - BTSG 6 3/4 02/01/27 | 177.13 | 14.50B | ||
| FMS | FRESENIUS MEDICAL CARE-ADR | 14.8 | 14.42B | ||
| HIMS | HIMS & HERS HEALTH INC | 95.91 | 9.22B | ||
| CHE | CHEMED CORP | 24.57 | 8.43B | ||
| CRVL | CORVEL CORP | 27.27 | 6.60B | ||
| OPCH | OPTION CARE HEALTH INC | 26.32 | 5.33B | ||
| RDNT | RADNET INC | 110.41 | 4.99B |
Related stock screener links
About GH
Company Profile
Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. The company is headquartered in Palo Alto, California and currently employs 1,779 full-time employees. The company went IPO on 2018-10-04. The company provides critical insights into what drives disease through its advanced blood and tissue tests, real-world data, and artificial intelligence (AI) analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and helping doctors select the best treatment for patients with advanced cancer. For patients with advanced-stage cancer, it has developed Guardant360 laboratory developed test (LDT), and Guardant360 CDx, a comprehensive liquid biopsy test to provide tumor mutation profiling with solid tumors and to be used as a companion diagnostic in connection with non-small cell lung cancer (NSCLC), and breast cancer. The company offers other tests, including Guardant360 TissueNext tissue test, Guardant Reveal blood test, Guardant360 Response blood test and others.
Company Info
GUARDANT HEALTH INC
3100 Hanover Street
Palo Alto CALIFORNIA 94063 US
CEO: Helmy Eltoukhy
Employees: 1774
Company Website: https://guardanthealth.com/
Investor Relations: https://investors.guardanthealth.com/
Phone: 18556988887
GH FAQ
What is the stock price of GH?
The current stock price of GH is 47.595 USD.
What is the symbol for GUARDANT HEALTH INC stock?
The exchange symbol of GUARDANT HEALTH INC is GH and it is listed on the Nasdaq exchange.
On which exchange is GH stock listed?
GH stock is listed on the Nasdaq exchange.
Is GH a good stock to buy?
Always make your own analysis. On these pages you can find a full technical and fundamental analysis report for GH, which may be a starting point for your analysis. You can also find the financials, news, analyst ratings and estimates here, which can be used to increase your understanding of GH.
Does GH stock pay dividends?
GH does not pay a dividend.
When does GH stock report earnings?
GH will report earnings on 2025-02-20, after the market close.
What is the Price/Earnings (PE) ratio of GH?
GH does not have a PE ratio as the earnings reported over the last twelve months were negative (-3.51).
What is the Short Interest ratio of GH stock?
The outstanding short interest for GH is 6.25% of its float.
GH Technical Analysis
ChartMill assigns a technical rating of 10 / 10 to GH. When comparing the yearly performance of all stocks, GH is one of the better performing stocks in the market, outperforming 96.45% of all stocks.
GH Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to GH. GH scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
GH Financial Highlights
Over the last trailing twelve months GH reported a non-GAAP Earnings per Share(EPS) of -3.51. The EPS increased by 13.55% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -33.3% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
GH Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 86% to GH. The Buy consensus is the average rating of analysts ratings from 31 analysts.
For the next year, analysts expect an EPS growth of 0.9% and a revenue growth 29.94% for GH